The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas - Wikidata - awgldk - TriplyDB

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

http://www.wikidata.org/entity/Q33744491

about

Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.Targeting colony stimulating factor 1 receptor to prevent cognitive deficits induced by fractionated whole-brain irradiation.Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy.Associations between prediagnostic blood glucose levels, diabetes, and glioma.Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages.Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.p53 Mutation: Critical Mediator of Therapy Resistance against Tumor Microenvironment.A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer Macrophages as Key Drivers of Cancer Progression and Metastasis.Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.Type I insulin-like growth factor receptor signaling in hematological malignancies.A novel serum microRNA-based identification and classification biomarker of human glioma.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.The Promise of Targeting Macrophages in Cancer Therapy.Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.Tumour-associated macrophages as treatment targets in oncology.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment.The Microenvironmental Landscape of Brain Tumors.Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Gastric adenocarcinoma.Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling.A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.Tumor suppressive role of miR-194-5p in glioblastoma multiforme.Mathematical modeling and computational prediction of cancer drug resistance.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.Glioma-induced SIRT1-dependent activation of hMOF histone H4 lysine 16 acetyltransferase in microglia promotes a tumor supporting phenotype.Immunotherapies for malignant glioma.

P2860

Q28066522-3CA8A87E-BDAF-465A-9859-4B56CF74BA4A Q30838654-A3503EE7-C0A4-48A9-9C93-A0AE04CD2752 Q33588532-2D85A8F7-5CC7-4E33-A5C0-DD84AFD9170A Q33664499-571A1014-33D9-4347-B71E-D3AB51E0FCAF Q33684013-0190F5A0-FB8B-4198-98E7-765DD6557FEB Q33744534-9D683A0E-7BEC-489D-B79A-F685760A4B3D Q33779328-F038DA99-F429-4BF4-95FA-592B03674ABD Q33837257-36A65601-F87D-48BB-9156-C8EBBC5B545E Q33912938-D355E19F-4FD8-4881-943C-32FE3F36BC3A Q37468744-F7CF0FFB-1D95-4FB6-8B0D-BDE4C7FD5D75 Q37580120-5BB598E6-0BA0-4F48-88CA-0543094C3492 Q37624909-441A3A0E-C3E7-4615-8A56-617B3733989F Q37660216-6C821F0D-BBAE-4B59-8D09-EC1D0D729EB6 Q37702186-E9B692F1-9FE2-4A76-9171-75CE22E04283 Q38433922-3693F226-B24A-4396-9E73-BA4020E6D32A Q38641329-6E7B943D-B30A-48C5-BF8D-C467EE45E5D2 Q38699394-E7DD13CA-CBA6-45A9-95D8-7257D4D9E84D Q38838354-0BDA8515-6D65-40BE-81C5-8F5DB176D439 Q38877313-1E3AF3D1-5EB6-4D4A-B20B-38DDC9A3C77B Q39003387-94C15891-5868-4CF2-86F3-A487DFEFB426 Q39022841-1CD4B74A-D96A-4CDC-956B-D6F1C0D215EE Q39100693-FE330C04-6322-4A70-ADF6-2EDCAECA86D8 Q39144794-9DE84F3A-23E1-48AA-BA0F-7BF84C1538EE Q39168810-00CAACCD-01A6-4C75-963C-AC79C8A097A0 Q39178065-0BE091D8-0ACC-4E37-9669-51C9EA6257F4 Q39196377-A989998D-7D82-4537-83F0-449D82A44E73 Q39267549-70AEAC97-5202-4CC0-88A7-C2EAA86328F8 Q39343374-D9399EE8-9F59-4A80-AEB3-640BCE634CCE Q42010694-ED021D13-C81C-49D7-BFEE-000A2D69589B Q43290383-0029D305-877B-4380-8DE1-5982DB8771EE Q46410671-DD76C374-F1A0-432D-8E1A-3518E7D70ECB Q47168980-DAE6DD77-C033-42E8-BDEF-B922BB429B80 Q47307094-584D0782-2BD4-455F-85E7-DDE9294B9F8F Q47388067-DD8EE7C4-5A1D-429F-8B7E-5E2ABC985BBF Q47660509-2FDF3070-EF13-48F6-860A-40DEAE095D68 Q47773621-85AB4842-D9B6-48B7-BB02-222A0A3C7993 Q47826206-A9AFB6C0-1C42-49BA-A2DE-916D054A793C Q47851037-0ECBCE55-788B-453D-9B3E-BF4F4A863F15 Q47879278-D1A6FD75-1560-4F11-9F05-7CECD41507FD Q47915209-6DBF230A-1096-44C5-9208-974DC64BB33F

P2860

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

http://www.wikidata.org/entity/Q33744491

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@ast

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@en

type

label

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@ast

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@en

prefLabel

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@ast

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@en

P1433

Q33744491-FD64ED2C-C777-4ADF-9791-04A6EBC612E5

P1476

Q33744491-E8E9DA51-B76B-4484-9E8D-47A013B018D6

P2093

Q33744491-1AECD058-0A7A-4582-9A5D-FF8255456AA8

Q33744491-29208A32-6D77-454D-8988-E3095012DFF4

Q33744491-2AD79729-DE0B-42BF-966B-042BADA048FE

Q33744491-5787408B-CE36-4A8A-963C-5AE5230EE17F

Q33744491-6A080FDC-4947-4E68-B7C9-223AB17B4BFA

Q33744491-BE22E5DA-0603-4EC5-83EF-9EB642DD60A9

Q33744491-E310AE0D-C27E-489D-AA11-4022525503E1

P2860

Q33744491-000C980D-C7FE-43F4-8B32-9F4783111585

Q33744491-03B2A8AA-65B5-4B71-AE48-E554FF03C6C2

Q33744491-0D981B36-7C86-4137-A097-C6EEDDE31F71

Q33744491-0E1B6294-B60A-4808-A907-42776C879A6F

Q33744491-19453F85-618E-4B4A-A86D-AA8B36733BE3

Q33744491-1B81DFD5-4CCD-4432-993D-CA750C55E4C9

Q33744491-1C90687F-3305-4CBF-B45F-31129CEC0601

Q33744491-1D0BBADA-B45F-4147-B27D-45F563DB4015

Q33744491-1D6FDE23-FE57-41B4-B0B0-21D28B59AA99

Q33744491-212B0A93-9167-43D5-A983-FC2CF45FF883

P304

Q33744491-B8710D7C-1160-4F8E-AB2C-F3EECF29CB5D

P31

Q33744491-06BD8822-6571-4DE4-9C1C-5E0E246DB8C6

P356

Q33744491-867A416F-CB00-4E01-B9DB-8F6080E8F8B3

P407

Q33744491-DD54D9ED-655C-4B2B-8C4B-2883D054AFAE

P433

Q33744491-A9909E8F-2F78-4164-BB37-1975EB661534

P478

Q33744491-839BA8F1-CAA4-4ECA-BC07-F644DFEB5AAD

P50

Q33744491-3C0FE322-CBA8-4B81-8B41-F393712373FF

Q33744491-58F280D4-4941-47BB-B6A4-0914128E074E

P577

Q33744491-50938465-C63F-4848-B28C-CC5D4CD6DE22

P698

Q33744491-01F3E415-5738-4CED-87BA-175DF2918B37

P932

Q33744491-A5820CEE-C891-43BF-A48C-A22ADEC1EA97

P356

SCIENCE.AAD3018

P1433

P1476

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

@en

P2093

Daniela F Quail

http://www.w3.org/2001/XMLSchema#string

Eric C Holland

http://www.w3.org/2001/XMLSchema#string

James C Sutton

http://www.w3.org/2001/XMLSchema#string

Jason T Huse

http://www.w3.org/2001/XMLSchema#string

Johanna A Joyce

http://www.w3.org/2001/XMLSchema#string

Marsha L Quick

http://www.w3.org/2001/XMLSchema#string

Robert L Bowman

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Exploring the full spectrum of macrophage activation

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

The 2007 WHO classification of tumours of the central nervous system

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

The Sequence Alignment/Map format and SAMtools

P304

aad3018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAD3018

http://www.w3.org/2001/XMLSchema#string

P407

P433

6288

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Alberto J Schuhmacher

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27199435

http://www.w3.org/2001/XMLSchema#string

P932

5450629

http://www.w3.org/2001/XMLSchema#string